COPD and the response of the lung to tobacco smoke exposure

Pulmonary Pharmacology and Therapeutics

Volumn 23, Issue 5, 2010, Pages 376-383

  Taylor, John D ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

COPD; Immune system; Inflammation; Tobacco smoke exposure

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; TOBACCO SMOKE;

AGING; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DISEASE EXACERBATION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LONG TERM EXPOSURE; LUNG FUNCTION; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

HUMANS; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 77955432423     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2010.04.003     Document Type: Review

References (95)

1. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997, 349:1498-1504.
2. Essata M., Lopez A.D. Estimates of Global mortality attributable to smoking in 2000. Lancet 2003, 362:847-852.
3. Bush A. COPD: a paediatric disease. COPD: J Chronic Obstructive Pulm Dis 2008, 5:53-67.
4. Vigel G., Pistelli F., Sherill D.L., Maio S., Baldacci S., Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Resp J 2007, 30:993-1010.
5. Hogg J.C., Timens W. The pathology of COPD. Annu Rev Pathol Mech Dis 2009, 4:435-459.
6. Seemungal T., Sykes A. Recent advances in exacerbations of COPD. Thorax 2008, 63:850-852. ICEAD contributors.
7. Halpern M.T., Stanford R.H., Borker R. The burden of COPD in the USA: results from the confronting COPD survey. Respir Med 2003, 97(Suppl. C):s81-s89.
8. Yoshida & Tuder. Pathobiology of cigarette smoke induced chronic pulmonary disease. Physiol Review (2).
9. Rennard S.I., Vestbo J. The many " small COPDs": COPD should be an orphan disease. Chest 2008, 134:623-627. 007; 87:1047-82.
10. Bals R., Hiemstra P.S. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J 2004, 23:327-333.
11. Bals R. Role of antimicrobial peptides in pulmonary disease. Mammalian host defense peptides 2004, Cambridge University Press, 349-374. 1st ed.
12. MacNee W. Accelerated lung aging: a novel pathogenic mechanism of COPD. Biochem Soc Trans 2009, 37:819-823.
13. Kirkwood T.B.L. Understanding the odd science of aging. Cell 2005, 120:437-447.
14. Hogg J.C., Senior R.M. Chronic obstructive pulmonary disease (c2): pathology and biochemistry of emphysema. Thorax 2002, 57:830-834.
15. Cerami C., Founds I., Nicholl I., Mitsuhashi T., Giorano D., Vanpatten S., et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci 1997, 1997(94):13915-13920.
16. Footitt J., Johnston S.L. Cough and viruses in airways disease: mechanisms. Pulm Pharmacol Ther 2009, 22(2):108-113.
17. Ning W., Li C.J., Kaminski N., Feghali-Bostwick C.A., Alber S.M., Di Y.P., et al. Comphrehensive gene expression profiles reveal pathways related to the pathogenesis of a chronic obstructive pulmonary disease. Proc Natl Acad Sci 2004, 101:14895-14900.
18. Pierrou S., Broberg P., O'Donnell R.A., Pawłowski K., Virtala R., Lindqvist E., et al. Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 175(6):577-586.
19. Wang I.M., Stepaniants S., Boie Y., Mortimer J.R., Kennedy B., Elliot M., et al. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. Am J Resp Crit Care Med 2008, 177:402-411.
20. Kelsen S., Duan X., Ji R., Perez O., Liu C., Merali S. Cigarette smoke induces an unfolded protein response in the human lung. Am J Resp Cell Mol Biol 2008, 38:541-550.
21. Adair-Kirk T., Atkinson J.L., Senior R.M. Smoke particulate stresses lung cells. Nat Med 2008, 14:1024-1025.
22. Dostert C., Pétrilli V., Van Bruggen R., Steele C., Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
23. Yang S.R., Chida A.S., Bauter M.R., Shafiq N., Seweryniak K., Maggirwar S.B., et al. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 2006, 291:L46-L57.
24. Kode A., Yang S.R., Rahman I. Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Resp Res 2006, 7:132.
25. Rangasamy T., Cho C.Y., Thimmulappa R.K., Zhen L., Srisuma S.S., Kensler T.W., et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 2004, 114:1248-1259.
26. Sussan T.E., Rangasamy T., Blake D.J., Malhotra D., El-Haddad H., Bedja D., et al. Targeting NFR2 with the triterpenoid CDDO-imidazole attenuates cigarette smoke-induced emphysema and cardiac function in mice. Proc Natl Acad Sci 2009, 106:250-255.
27. Blake D.J., Singh A., Kombairaju P., Malhotra D., Mariani T.J., Tuder R.M., et al. Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation. Am J Resp Cell Mol Biol 2009, June 11th.
28. Herr C., Beisswenger C., Hess C., Kandler K., Suttorp N., Welte T., et al. Suppression of pulmonary innate host defense in smokers. Thorax 2008, 64:144-149. Bals R for the CAPNETZ study group.
29. Van Wetering S., Sterk P.J., Rabe K.F., Hiemstra P.S. Defensins:key players or bystanders in infection, injury and repair in the lung?. J Allergy Clin Immunnol 1999, 104:1131-1138.
30. LeVine A.M., Whisett J.A. Pulmonary collectins and innate host defense of the lung. Microbes Infect 2001, 3:161-166.
31. Fitch P.M., Roghanian A., Howie S.E., Sallenave J.M. Human neutrophil elastase inhibitors in innate and adaptive immunity. Biochem Soc Trans 2006, 34:279-282.
32. Shibata Y., Abe S., Inoue S., Takabatake N., Igarashi A., Takeishi Y., et al. Altered expression of anti-microbial molecules in cigarette smoke exposed amphysematous mice lungs. Respirology 2008, 13:1061-1065.
33. Schleimer R.P. Innate immune responses and chronic obstructive pulmonary disease. " Terminator" or " Terminator 2" Proc Am Thorac Soc 2005, 2:342-346.
34. Schleimer R.P. Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc 2004, 1:222-230.
35. Louhelainen N., Rytila P., Haahtela T., Kinnula V., Dukanovic R. Persistence of oxidant and protease burden in the airways after smoking cessation. BMC Pulm Med 2009, 9:25. 10.1186/1471-2466-9-25.
36. Owen J.C. Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruc Pulmon Dis 2008, 3:253-268.
37. Scheuch G., Kohlhaufl M., Möller W., Brand P., Meyer T., Häussinger K., et al. Particle clearance from the airways of subjects with bronchial hyperesponsiveness and with COPD. Exp Lung Res 2008, 34:531-549.
38. Bhowmik A., Chahal K., Austin G., Chakravorty I. Improving mucociliary clearance in COPD. Respr Med 2008, 103:496-502.
39. Mall M., Harkema J.R., Trojanek J.B., Treis D., Livraghi A., Schubert S., et al. Development of chronic bronchitis & emphysema in ENac overexpression mice. Am J Resp Crit Care Med 2008, 177:730-742.
40. Tuder R.M., Yoshida T., Arap W., Pasqualini R., Petrache I. Cellular and molecular mechanisms of alveolar destruction in emphysema. An evolutionary perspective. Proc Am Thorac Soc 2006, 3:503-511.
41. MacNee W., Tuder R.M. New paradigms in the pathogenesis of COPD. Proc Am Thorac Soc 2009, 6:527-531.
42. Giordano R.J., Lahdenranta J., Zhen L., Chukwueke U., Petrache I., Larngley R.R., et al. Target induction of lung endothelial cell apoptosis causes emphysema like changes in the mouse. J Biol Chem 2008, 283(43):29447-29460.
43. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008, 8:183-192.
44. Doherty D., Downey G., Worthern G., Haslet C., Henson P. Monocyte retention and migration in pulmonary inflammation. Requirement for neutrophils. Lab Invest 1998, 59:200-213.
45. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002, 2:372-377.
46. Kirkham P.A., Spooner G., Rahman I., Rossi A.G. Macrophage phagocytosis of apoptotic neutrophils is compromised by matrix proteins modified by cigarette smoke and lipid peroxidation products. Biochem Biophys Res Commun 2004, 318:32-37.
47. Gaschler G.J., Zavitz C.C.J., bauer C.M.T., Skrtic M., Lindahl M., Robbins C.S., et al. Cigarette smoke exposure attenuates cytokine production by mouse alveolar macrophages. Am J Resp Cell Mol Biol 2008, 38:218-226.
48. Chung K.F., Adcock I.M. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Resp J 2008, 31:1334-1356.
49. Chaudhuri N., Dower S.K., Whyte M.K.B., Sabroe I. Toll like receptors and chronic lung disease. Clin Sci 2005, 109:125-133.
50. Doz E., Noulin N., Boichot E., Guenon I., Fick L., Le Bert M., et al. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signalling dependent. J Immunol 2008, 180:1169-1178.
51. Churg A., Zhou S., Wang X., Wang R., Wright J.L. The role of interleukin-1B in murine cigarette smoke induced emphysema and small airway remodelling. Am J Resp Cell Mol Biol 2009, 40:482-490.
52. Paul-Clark M.J., McMaster S.K., Sorrentino R., Sriskandan S., Bailey L.K., Moreno L., et al. Toll-like receptor 2 is essential for the sensing of oxidants during inflammation. Am J Respir Crit Care Med 2009, 179:299-306.
53. Bracke K.R., Demedts I.K., Joos G.F., Brusselle G. CC-chemokine receptors in COPD. Inflammation and Allergy - Drug Targets 2007, 6:75-79.
54. 17 cells in airway disease. Curr Mol Med 2008, 8:416-426.
55. Turato G., Di Stefano A., Maestrelli P., Mapp C.E., Ruggieri M.P., Roggeri A., et al. Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med 1995, 152:1262-1267.
56. Hogg J.C. Why does airway inflammation persist after the smoking stops?. Thorax 2006, 61:96-97.
57. Gamble E., Grootendoorst D.C., Hattotuwa T., O'Shaugnessy T., Ram F.S., Qiu Y., et al. Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis. Eur Respir J 2007, 30:467-471.
58. Lee S.H., Goswami S., Grudo A., Song L.Z., Bandi V., Goodnight-White S., et al. Antielastin autoimmunity in tobacco smoke induced emphysema. Nat Med 2007, 13:567-569.
59. Feghali-Bostwick C., Gadgil A.S., Otterbein E., Pliewski J.M., Stoner M., Csizmadia E., et al. Autoantibodies in patients with COPD. Am J Respir Crti Care Med 2008, 177:156-163.
60. Tarasevicience-Stewart L., Douglas I.S., Nan-Sinkam P.S., Lee J.D., Tuder R.M., Nicolls M.R., et al. Is alveolar destruction and emphysema in COPD an immune disease?. Proc Am Thorac Soc 2006, 3:687-690.
61. Korn S., Wiewrodt R., Walz Y.C., Becker K., Mayer E., Krummenauer F., et al. Characterization of the interstitial lung and peripheral blood T cell receptor repertoire in cigarette smokers. Am J Resp Cell Mol Biol 2005, 32:142-148.
62. Sullivan A.K., Simonian P.L., Falta M.T., Mitchell J.D., Cosgrove G.P., Brown K.K., et al. Oligoclonal CD4 T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med 2005, 172:590-596.
63. Motz G.T., Epprt B.L., Sun G., Wesselkamper S.C., Linke M.J., Deka R., et al. Persistence of lung CD8 T cell oligoclonal expansions upon smoking cessation in a mouse model of cigarette smoke induced emphysema. J Immunol 2008, 181:8036-8043.
64. Borchers M.T., Wesselkamper S.C., Curull V., Ramirez-Sarmiento A., Sanchez-Font A., Garcia-Aymerich J., et al. Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. J Clin Invest 2009, 10.1172/JCI/JCI34462.
65. Taylor J.D., Wregget K., Olsson H., Sjöbring U. Latest therapies targeting exacerbations in COPD. Drug Discov Today Ther Strategies 2008, 10.1016/j.ddstr.2008.06.003.
66. Sethi S., Murphy T.M. Infection in the pathogenesis and course of COPD. N Engl J Med 2008, 359:2355-2365.
67. Rosell A., Monso E., Soler N., Torres F., Angrill J., Riise G., et al. Microbiologic determinations of exacerbation in COPD. Arch Intern Med 2005, 165:891-897.
68. Larsen M.V., Janner J.H., Nielsen S.D., Friss-Moller A., Ringbaek T., Lange P. Bacteriology in acute exacerbation of COPD in patients admitted to hospital. Scand J Infect Dis 2009, 41:26-32.
69. Wedischa J.A. Antibiotics at COPD exacerbations: the debate continues. Thorax 2008, 63:940-942.
70. Dal Negro R., Michelett C., Tognella S., Visconti M., Turati C. Tobramycin nebuliser solution in severe COPD patients colonised with Pseudomonas aeruginosa: effects on bronchial inflammation. Advances Ther 2008, 1019-1030.
71. Martinez F.J., Curtis J.L., Albert R. Role of macrolide therapy in COPD. Int J Chron Obstructive Pulmonary Dis 2008, 3:331-350.
72. Lopez-Boado Y.S., Rubin B.K. Macrolides as immunomodultory medications for the therapy of chronic lung diseases. Curr Opin Pharmacol 2008, 8:286-291.
73. See H., Wark P. Innate immune reponses to viral infection of the lungs. Paediatr Respir Rev 2008, 9:243-250.
74. Proud D., Turner R.B., Winther B., Wiehler S., Tiesman J.P., Reichling T.D., et al. Gene expression profiles during in vivo human rhinovirus infection: insights into the host response. Am J Resp Crit Care Med 2008, 178:962-968.
75. Saijan U., Wang Q., Zhao Y., Gruenert D.C., Hershenson M.B. Rhinovirus disrupts the barrier function of polarised airway epithelial cells. Am J Resp Crit Care Med 2008, 178:1271-1281.
76. Kim K.D., Zhao J., Auh S., Yang X., Du P., Tang H., et al. Adaptive immune cells temper initial innate reponses. Nat Med 2007, 13:1248-1252.
77. Wiehler S., Proud D. Interleukin 17A modulates human airway epithelial responses to human rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 2007, 292:L505-L515.
78. Curtis J.L., Freeman C.M., Hogg J.C. The immunopathogenesis of COPD: insights from recent research. Proc A Thorac Soc 2007, 4:512-521.
79. Aldridge J.R., Mosely C.F., Boltz D.A., Negovetich N.J., Reynolds C., Franks J., et al. TNF/iNOS producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci USA 2009, 106:5306-5311.
80. Pamer E.G. Tiping the balance in favor of protective immunity during influenza infection. Proc Natl Acad Sci USA 2009, 106:4961-4962.
81. Kang M.-J., Geun Lee G., Lee J.-Y., Dela Cruz C.S., Chen Z.J., Enelow R., et al. Cigarette smoke selectively enhances viral PAMP and virus induced pulmonary innate immune and remodelling responses in mice. J Clin Invest 2008, 118:2771-2784.
82. Kim E.Y., Battaile J.T., Patel A.C., You Y., Agapov E., Grayson M.N., et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 2008, 14:633-640.
83. Wang Z., Zheng T., Zhu Z., Homer R.J., Riese R.J., Chapman H.A., et al. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 2000, 4:1587-1600.
84. Weathington N.M., van Houwelingen A.H., Noerager B.D., Jackson P.L., Kraneveld A.D., Galin F.S., et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med 2005, 12:317-323.
85. Houwelingen Van, Weathington N.M., Verweij V., Blalock J.E., Nijkamp F.P., Folkerts G. Induction of lung emphysema is prevented by L-arginine-threonine-arginine. FASEB J 2008, 22:3403-3408.
86. Hallberg J., Dominicus A., Erkisson U.K., Gerhardsson de Verdier M., Pedersen N.L., Dahläack M., et al. Interaction between smoking and genetic factors in the development of chronic bronchitis. Am J Respir Crit Care Med 2008, 177:486-490.
87. Hong Y.C., Lee K.H., Son B.K., Ha E.H., Moon H.S., Ha M. Effects of the GSTM1 and GSTT1 polymorphisms on the relationship between maternal exposure to environmental tobacco smoke and neonatal birth weight. J Occup Environ Med 2003, 45:492-498.
88. Tager I.B., Ngo L., Hanrahan J.P. Maternal smoking during pregnancy: effects on lung function during the first 18 months of life. Am J Resp Crit Care Med 1995, 152:977-983.
89. Janssens J.P., Pache J.C., Nicod L.P. Physiological chances in respiratory function associated with ageing. Eur Resp J 1999, 13:197-205.
90. Dorshkind K., Montecino-Rodriguex Encarnacion, Signer R.A. The ageing immune system: is it ever too old to become young again?. Nat Rev Immunol 2009, 9:57-62.
91. van den Biggelaar A.H., Huizinga T.W., de Craen A.J., Gussekloo J., Heijmans B.T., Frölich M., et al. Impaired innate immunity predicts frailty in old age. The Leiden 85 plus study. Exp Gerontol 2004, 39:1407-1414.
92. Ogawa Y., Duru E.A., Ameredes B.T. Role of IL-10 in the resolution of airway inflammation. Curr Mol Med 2008, 8:437-445.
93. Rajendrasozhan R., Yang S.R., Kinula V.L., Rahman I. SIRT1, an antinflammatory and antiaging protein is decreased in lungs of patients with COPD. Am J Resp Crit Care Med 2008, 177:861-870.
94. Tuder R. Aging and cigarette smoke: fueling the fire. Am J Resp & Critical Care Medicine 2006, 17:490-491.
95. Finch C.E., Crimmins E.M. Inflammatory exposure and historial changes in human life spans. Science 2004, 305:1736-1739.